Seven Eight Capital, LP Illumina, Inc. Transaction History

Seven Eight Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$101.05 - $133.57 $741,302 - $979,869	7,336 New	7,336 $765,000
Q2 2022 Aug 04, 2022	BUY	$181.58 - $368.0 $1.48 Million - $2.99 Million	8,130 Added 488.88%	9,793 $1.81 Million
Q1 2022 May 11, 2022	BUY	$303.87 - $423.8 $505,335 - $704,779	1,663 New	1,663 $581,000
Q3 2018 Oct 18, 2018	SELL	$279.04 - $367.06 $1.62 Million - $2.13 Million	-5,790 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$228.17 - $292.07 $958,314 - $1.23 Million	4,200 Added 264.15%	5,790 $1.62 Million
Q1 2018 May 14, 2018	BUY	$209.54 - $253.91 $20,954 - $25,391	100 Added 6.71%	1,590 $376,000
Q4 2017 Feb 12, 2018	SELL	$202.23 - $230.03 $4.41 Million - $5.02 Million	-21,810 Reduced 93.61%	1,490 $326,000
Q3 2017 Oct 16, 2017	BUY	$172.3 - $213.93 $4.01 Million - $4.98 Million	23,300	23,300 $4.64 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.